Examkin

Soru

Zorluk: Çok zorPharmacologic Interventions

A 32-year-old man with no known medical history is brought to the emergency department by emergency medical services (EMS). His roommate found him unresponsive and experiencing generalized tonic-clonic movements. EMS reports that the continuous seizure activity began 25 minutes ago. Paramedics established peripheral intravenous access en route but did not administer any medications. Upon arrival, the patient remains unresponsive with ongoing rhythmic jerking of his extremities. His blood pressure is 145/88 mm Hg, heart rate is 132/min, and oxygen saturation is 94% on a non-rebreather mask. Fingerstick blood glucose is 102 mg/dL. The emergency physician initiates a protocolized escalation for status epilepticus. Assuming the patient's seizures remain completely refractory to each successive pharmacological intervention, arrange the following therapies in the correct chronological sequence of administration, progressing from initial emergent therapy to salvage therapy for super-refractory status epilepticus.

  1. 1Intravenous lorazepam bolus
  2. 2Intravenous fosphenytoin bolus
  3. 3Continuous intravenous propofol infusion
  4. 4Continuous intravenous pentobarbital infusion

Cevap

The correct chronological sequence for the pharmacologic escalation of status epilepticus is: 1) Intravenous lorazepam bolus, 2) Intravenous fosphenytoin bolus, 3) Continuous intravenous propofol infusion, 4) Continuous intravenous pentobarbital infusion.
The pharmacological management of status epilepticus follows a strict, step-wise algorithm designed to rapidly terminate seizure activity while minimizing treatment-related morbidity. The sequence progresses chronologically from emergent fast-acting agents (benzodiazepines) to longer-acting antiepileptic drugs (fosphenytoin, valproate, or levetiracetam). If clinical or electrographic seizures persist, the patient enters refractory status epilepticus, requiring intubation and continuous anesthetic infusions (propofol or midazolam). Finally, if these first-line anesthetics fail, the patient is deemed super-refractory and escalated to highly toxic salvage therapies like pentobarbital coma.

Adım Adım Çözüm

1
Administer intravenous lorazepam bolus.
Addresses the Initial Therapy Phase (5-20 minutes).
Benzodiazepines rapidly enhance GABA-A receptor inhibition to emergently stop the clinical seizure. Even if the patient has been seizing for >20 minutes, if no drugs have been given, a benzodiazepine must be administered first.
2
Administer intravenous fosphenytoin bolus.
Addresses the Second-Therapy Phase (20-40 minutes).
Provides sustained antiepileptic coverage. Fosphenytoin blocks voltage-gated sodium channels to prevent seizure recurrence once the rapidly redistributing lorazepam wears off.
3
Initiate continuous intravenous propofol infusion.
Addresses Refractory Status Epilepticus (40-60 minutes).
When seizures fail to stop with initial bolus agents, general anesthesia with mechanical ventilation is required to definitively suppress cerebral metabolic demand and seizure activity.
4
Initiate continuous intravenous pentobarbital infusion.
Addresses Super-Refractory Status Epilepticus.
Reserved strictly as a salvage therapy when seizures continue despite standard continuous anesthetic infusions, providing profound burst-suppression at the cost of severe cardiovascular depression.

Anahtar Kavram

The step-wise pharmacological escalation protocol for status epilepticus.

Alternatif Yöntem

In the second-therapy phase, intravenous valproic acid or levetiracetam are equally effective, evidence-based alternatives to fosphenytoin according to the randomized ESETT trial.
Tahmini Süre:2m 0s
Bu soruyu puanla

Konular

Pharmacologic Interventions

Bu konudan daha fazla soru